GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Agile Therapeutics Inc (STU:0AL) » Definitions » Policyholder Funds

Agile Therapeutics (STU:0AL) Policyholder Funds


View and export this data going back to 2018. Start your Free Trial

What is Agile Therapeutics Policyholder Funds?

Policyholder Funds only applies to insurance companies.


Agile Therapeutics (STU:0AL) Business Description

Traded in Other Exchanges
Address
500 College Road East, Suite 310, Princeton, NJ, USA, 08540
Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin. The Company views its operations and manages its business in one operating and reporting segment, which is the business of commercializing its transdermal patch for use in contraception.